OXFORD HEARTBEAT
LIVE

Serial Number

90028708

Owner

Oxford Heartbeat Ltd

Attorney

Richard S. Finkelstein

Filing Date

Jun 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

OXFORD HEARTBEAT Trademark

Serial Number: 90028708

OXFORD HEARTBEAT is a trademark filed by Oxford Heartbeat Ltd on June 30, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Oxford Heartbeat Ltd (2 trademarks)

33 Great James Street, Flat A
London WC1N3HB , GB

Entity Type: 99

Trademark Details

Filing Date

June 30, 2020

Registration Date

Not Registered

Published for Opposition

June 9, 2026

Goods & Services

Providing on-line information in the medical field being the provision of medical information; Medical services; Minimally invasive surgical services; Rental of medical apparatus and instruments; Surgery; Veterinary services; Medical analysis services relating to patient treatment, namely, web-based vascular and arterial analysis services for medical diagnostic and treatment purposes; Medical and surgical diagnostic services, namely, medical diagnosis of Vascular and arterial disorders and abnormalities; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereof

Downloadable computer software for use in the simulation of blood flow; Downloadable computer software for use in the simulation of blood flow in relation to vessel and arterial diseases and abnormalities; Downloadable computer software for use in the simulation of blood flow in relation to vessel and arterial diseases and abnormalities for use in the medical and surgical field; Downloadable computer software for use in the simulation of blood flow in relation to vessel and arterial diseases and abnormalities for use in the veterinary field; Downloadable computer software for enabling the storage, retrieval, transmission and processing of data and information; Downloadable computer software for enabling the storage, retrieval, transmission and processing of data and information for medical purposes; Downloadable computer software for use in decision support systems and real time surgery support and visualisation; downloadable computer software for use in medical decision support systems; Downloadable computer software for medical image processing, anatomy visualisation and analysis, diagnosis and treatment simulations, predictions and suggestions for use in machine learning; Downloadable computer software for medical image processing, anatomy visualisation and analysis, diagnosis and treatment simulations, predictions and suggestions for use in machine learning for medical purposes; Downloadable computer software applications for the provision of access to advice and information; Downloadable computer software applications for the provision of access to medical advice and information; Downloadable computer software for use in creating computer generated models and simulations; Downloadable computer software for use in creating computer generated models and simulations of medical data; Virtual reality models being downloadable virtual reality software for use in medical teaching; Medical diagnostic simulators for use as teaching aids for surgeries for the treatment of blood vessel and arterial diseases and abnormalities; Electronic data processing apparatus; headmounted display apparatus, namely, Head-mounted video displays; computer display screens; scanners being data processing apparatus; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereof

Computer modelling and design of computer-simulated models of human anatomy and treatment options related to vessel and arterial diseases and abnormalities; Computer modelling and design of computer-simulated models of human anatomy and treatment options related to vessel and arterial diseases and abnormalities including for the purposes of diagnostics, pre-operative planning and real time surgery support and visualization; Design and development of medical apparatus, namely, design and testing for new product development; Design and development of medical technology, namely, design and testing for new product development; Medical device design services being new product design services; Simulations of the deployment and manual manipulation of vascular medical devices being simulation of manual manipulation by clinicians in the nature of medical research services; Custom design of medical devices for others being new product design services; Software as a Service (SAAS) services featuring software for medical image processing, anatomy visualisation and analysis, diagnosis and treatment simulations, predictions and suggestions for medical use in the field of vascular and arterial diseases and abnormalities and their associated treatments; Software as a Service (SAAS) services featuring software for simulation of blood flow as relevant to vascular and arterial diseases and abnormalities and their associated treatments for use in the medical field; Software as a Service (SAAS) services featuring software for Simulation of blood flow as relevant to vascular and arterial diseases and abnormalities and their associated treatments for use in the veterinary field; Virtualizing surgical procedures, namely, services in the nature of computer modelling of surgical procedures; Computer modelling and simulating of human, biological and synthetic organs and fluids, being computer modelling services; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereof

Compilation of information into computer databases; Data processing services; Data processing services in the medical and surgical field; Data processing services in the veterinary field; Database management; Database management in the medical field; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereof

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 11, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
May 11, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 11, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
May 11, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 11, 2026 CNEA
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jan 23, 2026 GNS1
SUBSEQUENT FINAL EMAILED
Jan 23, 2026 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Jan 23, 2026 CFRC
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 23, 2026 GNFN
FINAL REFUSAL E-MAILED
Jan 23, 2026 GNFR
FINAL REFUSAL WRITTEN
Jan 23, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 8, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 8, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 8, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 4, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 4, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 4, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 4, 2025 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 17, 2025 RCCK
ASSIGNED TO EXAMINER
Mar 4, 2025 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 7, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 5, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 5, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jul 5, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 22, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 22, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 22, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 22, 2024 CNRT
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jan 22, 2024 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 18, 2024 PARI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 12, 2024 RCCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2024 CRFA
ASSIGNED TO LIE
Jan 12, 2024 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 2, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 2, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jun 2, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 11, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 29, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 29, 2022 GNSL
SUSPENSION LETTER WRITTEN
Dec 29, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 29, 2022 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 8, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 8, 2022 GNSL
SUSPENSION LETTER WRITTEN
Aug 8, 2022 CNSL
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 5, 2022 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 13, 2022 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 15, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 13, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
May 13, 2021 GNSL
SUSPENSION LETTER WRITTEN
May 13, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 14, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 14, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 4, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2020 NWOS
NEW APPLICATION ENTERED
Jul 3, 2020 NWAP